Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-15 Sale |
2023-05-17 4:58 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
11,965 | $29.03 | $347,358 | 257,591 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 7:45 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,579 | $30.54 | $1,513,942 | 269,556 (Direct) |
View |
| 2023-03-29 Sale |
2023-03-31 4:05 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
29,048 | $30.45 | $884,512 | 6,997,302 (Direct) |
View |
| 2023-03-27 Sale |
2023-03-29 4:05 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
160,964 | $30.42 | $4,896,561 | 7,026,350 (Direct) |
View |
| 2023-03-16 Sale(A) |
2023-03-24 6:48 pm |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
32,500 | $31.89 | $1,036,459 | 567,676 (Direct) |
View |
| 2023-03-16 Sale(A) |
2023-03-24 6:45 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
54,627 | $31.87 | $1,741,200 | 360,385 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 4:05 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
63,448 | $31.91 | $2,024,494 | 7,187,314 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:31 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer |
100,000 | $31.86 | $3,186,236 | 3,067,617 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:25 pm |
Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director |
35,000 | $31.89 | $1,116,072 | 862,021 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:25 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
54,627 | $31.87 | $1,741,200 | 200,089 (Direct) |
View |
| 2023-03-16 Purchase |
2023-03-20 8:22 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director |
1,000 | $31.99 | $31,990 | 28,403 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:21 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
100,000 | $31.86 | $3,186,336 | 3,067,617 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:18 pm |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
32,500 | $31.89 | $1,036,459 | 120,676 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-17 4:05 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
9,122 | $32.55 | $296,921 | 7,250,762 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 4:11 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
220,714 | $33.68 | $7,433,459 | 7,259,884 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 09:10 am |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
50,000 | $33.75 | $1,687,500 | 7,480,598 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-28 4:42 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer |
3,586 | $34.49 | $123,672 | 37,414 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-28 4:06 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
50,000 | $34.73 | $1,736,352 | 7,530,598 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-24 4:13 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
100,000 | $35.78 | $3,578,103 | 7,580,598 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:22 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,034 | $36.3 | $73,831 | 204,299 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:20 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
5,968 | $36.3 | $216,629 | 2,892,617 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:20 pm |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
2,658 | $36.3 | $96,481 | 34,009 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:19 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
2,403 | $36.3 | $87,225 | 214,355 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:12 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer |
5,968 | $36.3 | $216,629 | 2,892,617 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-09 9:48 pm |
Amylyx Pharmaceuticals Inc. | AMLX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon DRAGSA 96 LLC 10% Owner |
1,400,000 | $29.8 | $41,719,639 | 1,850,940 (Indirect) |
View |
| 2022-07-06 Sale |
2022-07-08 6:44 pm |
Amylyx Pharmaceuticals Inc. | AMLX | ALS Invest 1 B.V. 10% Owner |
60,609 | $20.7 | $1,254,642 | 5,895,280 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,201 | $0.37 | 257,591 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
9,764 | $6.88 | 257,591 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A 2029-03-18 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
11,965 | $0 | 257,591 (Direct) |
View |
| 2022-01-06 Conversion(A) |
2023-04-26 7:34 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
19,482 | $0 | 19,482 (Indirect) |
View |
Ownership(A) |
2023-04-26 7:30 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
0 | $0 | 19,482 (Indirect) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
44,861 | $0.37 | 269,556 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
4,718 | $6.88 | 269,556 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A 2029-03-18 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,579 | $0 | 269,556 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:48 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
32,500 | $6.88 | 567,676 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:48 pm |
N/A 2031-01-25 |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
32,500 | $0 | 567,676 (Direct) |
View |
| 2023-03-16 Option Award(A) |
2023-03-24 6:48 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
119,167 | $0 | 567,676 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,789 | $0.33 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
30,041 | $0.37 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
16,748 | $6.88 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A 2028-02-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,578 | $0 | 360,385 (Direct) |
View |
| 2023-03-16 Option Award(A) |
2023-03-24 6:45 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
50,417 | $0 | 360,385 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:31 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer |
275,000 | $0 | 3,067,617 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:27 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer |
100,833 | $0 | 315,188 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:25 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
50,417 | $0 | 200,089 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:25 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer |
100,833 | $0 | 138,247 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:22 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director |
27,403 | $0 | 28,403 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:21 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
275,000 | $0 | 3,067,617 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:18 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
119,167 | $0 | 120,676 (Direct) |
View |
| 2022-01-06 Ownership |
2023-02-14 4:35 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director |
1,378,850 | $0 | 897,021 (Direct) |
View |
| 2022-12-29 Ownership |
2023-02-14 4:35 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director |
13,800 | $0 | 897,021 (Direct) |
View |
| 2022-09-12 Ownership |
2023-01-11 4:07 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner |
1,376,666 | $0 | 7,680,598 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 9:33 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
5,000 | $6.88 | 483,667 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 9:33 pm |
N/A 2031-01-25 |
Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer |
5,000 | $0 | 483,667 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:05 pm |
N/A 2032-06-09 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:05 pm |
N/A 2032-06-09 |
Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:05 pm |
N/A 2032-06-09 |
Amylyx Pharmaceuticals Inc. | AMLX | Cheng Isaac Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:05 pm |
N/A 2032-06-09 |
Amylyx Pharmaceuticals Inc. | AMLX | Quimi Daphne Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer |
334,520 | $0.37 | 2,898,585 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A 2023-02-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer |
334,520 | $0 | 2,898,585 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
334,520 | $0.37 | 2,898,585 (Direct) |
View |
| 2022-05-05 Exercise |
2022-05-06 4:05 pm |
N/A 2023-02-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer |
334,520 | $0 | 2,898,585 (Direct) |
View |